Adam Hoyhtya is Vice President, Clinical & Regulatory at Neurotronic and a clinical and regulatory affairs leader with more than 20 years of experience guiding medical-device and drug-device combination programs from early development through pivotal clinical trials. He has led cross-functional teams in protocol design, regulatory strategy, vendor oversight, and trial execution across multiple therapeutic areas, with a particular focus on novel structural-heart therapies and, more recently, treatments for hypertension and cardiometabolic disease. His work combines rigorous scientific methods and a strong emphasis on data quality with practical, real-world approaches to clinical-trial design and delivery. Adam holds a BS from Johns Hopkins University and an MS in Electrical Engineering from the Massachusetts Institute of Technology.